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This map displays the locations of lung cancer screening facilities in Maryland
and  the  estimated  target  population  for  lung  cancer  screening  in  each
jurisdiction, based on current smoking rates (for 2015). Each location may
have 1, 2, or all 3 types of screening facilities. Of the 119 screening facilities,
68 were unique. This map informed the Maryland Department of Health’s lung
cancer  screening  pilot  program  by  providing  estimates  of  the  eligible
population for lung cancer screening by jurisdiction and showing areas with
existing resources for lung cancer screening. Map created by Lisa D. Gardner
on July 26, 2017. Abbreviation: ACR, American College of Radiology.
 
Background
Lung cancer is the leading cause of cancer death in Maryland, and
it is the third most common cancer after female breast and pro-
state cancers (1). In 2013, more than 2,600 Marylanders died of
lung cancer (1). Most lung cancer cases are diagnosed after meta-
stasis, so the 5-year survival rate is low at 18.1% (2). Finding lung
cancer early drastically improves survival; the 5-year survival rate
for localized lung cancer is 55.6% (2). Cigarette smoking is the
primary risk factor for lung cancer. In 2015, 15.2% of Maryland
adults (aged ≥18) were current smokers (1).
In 2011, the National Lung Screening Trial showed that annual
screening with low-dose computed tomography (LDCT) in high-
risk individuals reduced mortality from lung cancer by 20% (3).
As a result, the National Comprehensive Cancer Network recom-
mends annual LDCT screening of asymptomatic high-risk indi-
viduals, defined as the following: 1) adults aged 55 to 74 with a
smoking history of 30 pack-years or more and smoking cessation
for less than 15 years or 2) adults aged 50 or older with a smoking
history of 20 pack-years or more and at least 1 additional risk
factor (eg, cancer history) other than second-hand smoke (4). The
US Preventive Services Task Force also recommends annual LD-
CT screening for lung cancer among certain high-risk individuals.
Cancer prevention and control under Maryland’s Cigarette Resti-
tution Fund Cancer Prevention, Education, Screening and Treat-
ment Program (CRF-CPEST) is a high priority for the Maryland
Department of Health (1). The goal of CRF-CPEST is to reduce
cancer mortality and morbidity rates in the state through imple-
mentation of community-based programs to prevent, detect, and/or
treat cancer early. CRF-CPEST programs provide community edu-
cation and outreach, funding to assist uninsured and underinsured
Marylanders in obtaining access to cancer screenings, and case
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management to ensure linkage to screening, diagnosis, and treat-
ment.  Because lung cancer is 1 of 7 cancers targeted by CRF-
CPEST, we evaluated the resources and need for establishing a pi-
lot program for lung cancer screening in Maryland.
Methods
Given that cigarette smoking is the main risk factor for lung can-
cer, we estimated smoking rates by jurisdiction (23 counties and
Baltimore City) in Maryland to determine areas with the highest
rates. Smoking rates from 2015 were estimated according to a stat-
istical model that combined information from the Behavioral Risk
Factor Surveillance System and the National Health Interview
Survey to correct for nonresponse and under-coverage bias; this
model is enhanced in small areas by borrowing information from
similar areas nationally (5).
We identified lung cancer screening facilities in Maryland by us-
ing 3 publicly available sources: 1) the American College of Radi-
ology’s (ACR’s) Lung Cancer Screening Registry, which is ap-
proved by the Centers for Medicare and Medicaid Services and
enables providers to meet quality reporting requirements for re-
ceiving Medicare payments for lung cancer screening with LDCT;
2) the ACR Lung Cancer Screening Center designation, which
identifies facilities that have achieved ACR accreditation for com-
puted tomography in at least the chest module and provide safe,
effective diagnostic care for those at high risk for lung cancer; and
3) the Lung Cancer Alliance’s Screening Centers of Excellence,
which are organizations identified as being committed to respons-
ible,  high-quality  screening  practices.  We then  geocoded  and
mapped these facilities in ArcGIS version 10.4 (Environmental
Systems Research Institute, Inc) to determine jurisdictions that had
lung cancer screening capabilities.
Findings
The  map  shows  the  percentage  of  adults  who  were  current
smokers in 2015 by jurisdiction. These percentages vary consider-
ably from the state percentage (15.2%),  ranging from 8.7% to
23.6%. Smoking rates were highest in Baltimore City, the lower
Eastern Shore (Caroline, Dorchester,  Somerset,  and Wicomico
counties), western Maryland (Allegany, Garrett, and Washington
counties), and Cecil County. Only 2 counties (Montgomery and
Howard) meet the 2020 Healthy People objective (12.0%) for re-
ducing tobacco use among US adults (6).
As of July 2017, 119 lung cancer screening facilities were identi-
fied in Maryland: 1) 64 ACR Lung Cancer Screening Registry fa-
cilities, 2) 46 ACR-Designated Lung Cancer Screening Centers,
and 3) 9 LCA Screening Centers of Excellence. Each facility is
equipped to screen for lung cancer per ACR guidelines. The distri-
bution of LDCT screening facilities reflects Maryland’s popula-
t ion  dens i ty ,  wi th  h ighly  popula ted  a reas  (eg ,  the
Baltimore–Washington metropolitan area) having more facilities.
Major highways are also displayed to demonstrate the accessibil-
ity of each facility to residents throughout the state.
Action
The Maryland Department of Health’s CRF-CPEST Program initi-
ated a lung cancer screening pilot program in fiscal year 2018. The
pilot’s  goal  is  to  assist  uninsured  and  underinsured  high-risk
Marylanders in obtaining access to life-saving screening, diagnost-
ic, and treatment services for lung cancer. In the 5-year period
from 2010 through 2014, 11 of 24 Maryland jurisdictions had sig-
nificantly higher lung cancer mortality rates than the state rate of
43.1 per 100,000 (1). This pilot will help diagnose lung cancer
cases at an earlier stage, improving survival and decreasing mor-
tality.  The pilot  will  also establish a  working model  for  other
CRF-CPEST programs that plan to implement lung cancer screen-
ing.
This map informed leadership of the Maryland Department of
Health of the estimated eligible population for lung cancer screen-
ing (ie, percentage of adults who are current smokers) by jurisdic-
tion and showed areas with resources for lung cancer screening.
Although current smoking rates do not reflect the entire popula-
tion at high risk for lung cancer, these rates are the only reliable
risk data available.  Because they exclude former smokers,  the
rates likely underestimate the population at high risk for lung can-
cer.
Eleven programs from 10 jurisdictions submitted applications to
CRF-CPEST to participate in the pilot program. Selection of pilot
participants was made according to the need and current resources
of each jurisdiction, as demonstrated in our map, as well as their
responses to an interview designed to assess readiness to imple-
ment lung cancer screening. Six programs (Allegany, Baltimore,
Cecil, Harford, and Wicomico counties, and MedStar Health in
Baltimore City) were selected to participate in the lung cancer
screening pilot program for fiscal year 2018. All applicants, re-
gardless of pilot program participation status, were extended invit-
ations to attend training sessions throughout fiscal year 2018.
This map was also used to identify jurisdictions in which the pre-
valence of current smoking was higher than the state rate and that
lack LDCT screening facilities but are interested in offering lung
cancer screening services to their communities. These jurisdic-
tions will be provided with technical assistance to ensure that lung
cancer screening can be implemented in future years.
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